Barclays’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
343,526
+260,295
| +313% | +$1.04M | ﹤0.01% | 2459 |
|
|
2025
Q1 | $264K | Sell |
83,231
-22,788
| -21% | -$72.3K | ﹤0.01% | 3188 |
|
|
2024
Q4 | $567K | Buy |
106,019
+106,018
| +10,601,800% | +$567K | ﹤0.01% | 2981 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4335 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4207 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4176 |
|
|
2023
Q4 | $0 | Sell |
1
-13,681
| -100% | – | ﹤0.01% | 4222 |
|
|
2023
Q3 | $20K | Buy |
13,682
+13,681
| +1,368,100% | +$20K | ﹤0.01% | 3903 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4272 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4316 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4397 |
|
|
2022
Q3 | $0 | Sell |
1
-9,670
| -100% | – | ﹤0.01% | 4664 |
|
|
2022
Q2 | $10K | Sell |
9,671
-1,425
| -13% | -$1.47K | ﹤0.01% | 4308 |
|
|
2022
Q1 | $18K | Sell |
11,096
-497
| -4% | -$806 | ﹤0.01% | 4353 |
|
|
2021
Q4 | $28K | Buy |
11,593
+11,592
| +1,159,200% | +$28K | ﹤0.01% | 3081 |
|
|
2021
Q3 | $0 | Sell |
1
-3
| -75% | – | ﹤0.01% | 3971 |
|
|
2021
Q2 | $0 | Sell |
4
-533
| -99% | – | ﹤0.01% | 4093 |
|
|
2021
Q1 | $2K | Buy |
537
+533
| +13,325% | +$1.99K | ﹤0.01% | 3823 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 3556 |
|
|
2020
Q3 | $0 | Sell |
4
-2,205
| -100% | – | ﹤0.01% | 3754 |
|
|
2020
Q2 | $6K | Buy |
2,209
+2,198
| +19,982% | +$5.97K | ﹤0.01% | 3680 |
|
|
2020
Q1 | $0 | Sell |
11
-12
| -52% | – | ﹤0.01% | 3689 |
|
|
2019
Q4 | $0 | Sell |
23
-53
| -70% | – | ﹤0.01% | 3910 |
|
|
2019
Q3 | $0 | Sell |
76
-13,556
| -99% | – | ﹤0.01% | 4159 |
|
|
2019
Q2 | $51K | Buy |
13,632
+9,637
| +241% | +$36.1K | ﹤0.01% | 3822 |
|
|
2019
Q1 | $16K | Buy |
3,995
+3,852
| +2,694% | +$15.4K | ﹤0.01% | 3948 |
|
|
2018
Q4 | $0 | Sell |
143
-5,137
| -97% | – | ﹤0.01% | 4133 |
|
|
2018
Q3 | $46K | Buy |
5,280
+4,260
| +418% | +$37.1K | ﹤0.01% | 3759 |
|
|
2018
Q2 | $12K | Sell |
1,020
-1,347
| -57% | -$15.8K | ﹤0.01% | 3835 |
|
|
2018
Q1 | $27K | Buy |
2,367
+773
| +48% | +$8.82K | ﹤0.01% | 3757 |
|
|
2017
Q4 | $17K | Buy |
1,594
+1,134
| +247% | +$12.1K | ﹤0.01% | 3740 |
|
|
2017
Q3 | $7K | Buy |
460
+421
| +1,079% | +$6.41K | ﹤0.01% | 3537 |
|
|
2017
Q2 | $0 | Sell |
39
-76
| -66% | – | ﹤0.01% | 3891 |
|
|
2017
Q1 | $2K | Sell |
115
-45
| -28% | -$783 | ﹤0.01% | 3770 |
|
|
2016
Q4 | $2K | Buy |
160
+139
| +662% | +$1.74K | ﹤0.01% | 3591 |
|
|
2016
Q3 | $0 | Buy |
+21
| New | – | ﹤0.01% | 3943 |
|